EG19217A - Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof - Google Patents

Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof

Info

Publication number
EG19217A
EG19217A EG7689A EG7689A EG19217A EG 19217 A EG19217 A EG 19217A EG 7689 A EG7689 A EG 7689A EG 7689 A EG7689 A EG 7689A EG 19217 A EG19217 A EG 19217A
Authority
EG
Egypt
Prior art keywords
intermediates
preparation
tetrazole compounds
antihypercholesterolemic
antihypercholesterolemic tetrazole
Prior art date
Application number
EG7689A
Other languages
English (en)
Inventor
William T Han
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of EG19217A publication Critical patent/EG19217A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/081,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
EG7689A 1988-02-18 1989-02-15 Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof EG19217A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/156,865 US4824959A (en) 1988-02-18 1988-02-18 Intermediates for antihypercholesterolemic tetrazole compounds

Publications (1)

Publication Number Publication Date
EG19217A true EG19217A (en) 1995-09-30

Family

ID=22561419

Family Applications (1)

Application Number Title Priority Date Filing Date
EG7689A EG19217A (en) 1988-02-18 1989-02-15 Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof

Country Status (32)

Country Link
US (1) US4824959A (it)
JP (2) JP2871707B2 (it)
KR (1) KR970002233B1 (it)
CN (1) CN1025619C (it)
AT (1) AT401057B (it)
AU (1) AU621586B2 (it)
BE (1) BE1002136A5 (it)
CA (1) CA1340430C (it)
CH (1) CH680792A5 (it)
CY (1) CY1874A (it)
DD (4) DD285600A5 (it)
DE (1) DE3904899A1 (it)
DK (1) DK75289A (it)
EG (1) EG19217A (it)
ES (1) ES2017810A6 (it)
FI (1) FI890725A (it)
FR (1) FR2630112B1 (it)
GB (1) GB2216121B (it)
GR (1) GR1000664B (it)
HK (3) HK129395A (it)
HU (2) HU204045B (it)
IE (1) IE65090B1 (it)
IT (1) IT1230750B (it)
LU (1) LU87456A1 (it)
MY (1) MY106279A (it)
NL (1) NL8900397A (it)
NO (1) NO172439C (it)
NZ (1) NZ227935A (it)
PT (1) PT89748B (it)
SE (2) SE503179C2 (it)
YU (1) YU34189A (it)
ZA (1) ZA891239B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
GB2244706B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole intermediates
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
DE4128345C1 (en) * 1991-08-27 1993-06-09 Hoechst Ag, 6230 Frankfurt, De 3R,5S 3,5,6-tri:hydroxy-hexanoic acid isopropylidene ketal derivs. prepn. - from 7-benzyl:oxy 4,6-di:hydroxy:heptene by multistage process
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE10147030A1 (de) * 2001-09-04 2003-03-27 Forschungszentrum Juelich Gmbh Verfahren zur Trennung diastereomerer 1,3-Diol-Acetale
US20050272808A1 (en) * 2004-05-11 2005-12-08 Nadav Zamir Compositions and methods for the treatment of hypertension
EP1746988A1 (en) * 2004-05-11 2007-01-31 Darley Pharmaceuticals Ltd. Spiroderivatives for the treatment of hypertension
CN104303915B (zh) * 2014-08-25 2016-05-25 李世峰 一种机插水稻水浮式育秧技术

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58225085A (ja) * 1982-06-24 1983-12-27 Nippon Kayaku Co Ltd アセタ−ルグリコ−ルジアクリレ−トおよびその製造法
US4808621A (en) * 1986-07-07 1989-02-28 Warner-Lambert Company Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4837205A (en) * 1986-09-02 1989-06-06 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4751229A (en) * 1987-07-09 1988-06-14 Warner-Lambert Company Treating fungal infections with substituted-(6-(tetrahydro-4-hydroxy-2-oxo-2H-pyran-2-yl)ethyl)- or ethenyl)pyrazoles
DE3807929A1 (de) * 1988-03-10 1989-09-28 Basf Ag Verfahren zur herstellung von reliefformen

Also Published As

Publication number Publication date
IT8919474A0 (it) 1989-02-17
AU3007589A (en) 1989-08-24
YU34189A (en) 1991-02-28
NL8900397A (nl) 1989-09-18
GR1000664B (el) 1992-09-25
DD283618A5 (de) 1990-10-17
SE8900565L (sv) 1989-08-19
HU209905B (en) 1994-11-28
SE9300595D0 (sv) 1993-02-23
HK47596A (en) 1996-03-29
MY106279A (en) 1995-04-29
KR890012992A (ko) 1989-09-20
SE9300595A0 (sv) 1993-02-23
GB8903604D0 (en) 1989-04-05
DD285600A5 (de) 1990-12-19
HUT50809A (en) 1990-03-28
HUT50167A (en) 1989-12-28
HK129295A (en) 1995-08-24
CH680792A5 (it) 1992-11-13
CY1874A (en) 1996-04-05
DK75289D0 (da) 1989-02-17
JP2871707B2 (ja) 1999-03-17
IE65090B1 (en) 1995-10-04
FI890725A (fi) 1989-08-19
JP2922887B2 (ja) 1999-07-26
CN1025619C (zh) 1994-08-10
GB2216121A (en) 1989-10-04
AU621586B2 (en) 1992-03-19
FI890725A0 (fi) 1989-02-15
NO890661L (no) 1989-08-21
HK129395A (en) 1995-08-24
IE890523L (en) 1989-08-18
ES2017810A6 (es) 1991-03-01
NO172439B (no) 1993-04-13
ATA36189A (de) 1995-10-15
CN1036013A (zh) 1989-10-04
FR2630112B1 (fr) 1994-07-29
LU87456A1 (fr) 1989-09-20
DD285603A5 (de) 1990-12-19
NO172439C (no) 1993-07-21
SE8900565D0 (sv) 1989-02-17
JPH115791A (ja) 1999-01-12
SE503179C2 (sv) 1996-04-15
JPH01249771A (ja) 1989-10-05
HU204045B (en) 1991-11-28
PT89748B (pt) 1994-05-31
US4824959A (en) 1989-04-25
NZ227935A (en) 1990-07-26
ZA891239B (en) 1991-12-24
PT89748A (pt) 1989-10-04
AT401057B (de) 1996-06-25
DE3904899A1 (de) 1989-08-31
BE1002136A5 (fr) 1990-07-24
DD285602A5 (de) 1990-12-19
FR2630112A1 (fr) 1989-10-20
NO890661D0 (no) 1989-02-16
DK75289A (da) 1989-08-19
GB2216121B (en) 1992-07-15
IT1230750B (it) 1991-10-29
CA1340430C (en) 1999-03-09
KR970002233B1 (ko) 1997-02-26

Similar Documents

Publication Publication Date Title
ZA931935B (en) Preparation of substituted guanidines
TW414158U (en) Construction of structural body
EG19217A (en) Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
TW236610B (en) Preparation of dinitrotoluene
EP0419856A3 (en) Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
ZA899778B (en) Reduction of piperidine-dion-derivatives and intermediates
GB2244705B (en) Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
IL88880A (en) Preparation of halopyridine intermediates and some such novel compounds
GB2202845B (en) Intermediates and processes for the preparation of antihypercholesterolemic tetrazole compounds
GB2249492B (en) Crystallisation of materials
ZA932553B (en) New use of B-carbolines
IL89305A0 (en) Preparation of antihypercholesterolemic tetrazole compounds and intermediates therefor
GB2265623B (en) Preparation of n-vinyl-o-alkyl carbamate
AU4341193A (en) Analysis and synthesis of rhythm
IL105485A0 (en) Intermediates for the preparation of antihypercholesterolemic compounds and their preparation
ZA881278B (en) Intermediates and processes for the preparation of antihypercholesterolemic tetrazole compounds
EP0431292A3 (en) Film-type combination of materials
EP0553954A3 (en) Preparation of tetramethyldiamino-polyoxyethylenes
KR950000006Y1 (en) Fastenings of sport-shoes
IL105486A0 (en) Intermediates for the preparation of antihypercholesterolemic compounds
GB2282810B (en) Preparation or purification of clavulanic acid
EP0353295A4 (en) NOVEL IMPROVED ANTIBODIES FOR SITE SPECIFIC FIXING OF COMPOUNDS.
IL89907A0 (en) New use of tetrazole derivatives
GB9203348D0 (en) New use of wf13533 substance
GB9206138D0 (en) Novel use of pharmaceutical compounds